<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01145326</url>
  </required_header>
  <id_info>
    <org_study_id>OUDEM 2010-1</org_study_id>
    <nct_id>NCT01145326</nct_id>
  </id_info>
  <brief_title>Functional Microarray Augmentation of Skin Treatment With Lidocaine</brief_title>
  <acronym>FAST</acronym>
  <official_title>Functional Microarray Augmentation of Skin Treatment With Lidocaine (FAST Lidocaine)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oklahoma</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Oklahoma</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether co-application of a functional microarray
      of needles (FMA) speeds the rate at which topical anesthesia is provided. A secondary goal is
      to determine whether the depth of anesthesia is enhanced.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study's primary goal is to determine whether co-application of a functional microarray of
      needles (FMA) speeds the rate at which topical anesthesia is provided by lidocaine gel 4%
      (LG4). A secondary goal is to determine whether the depth of anesthesia is enhanced.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    The device is undergoing further study in China, per FDA requirements.
  </why_stopped>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Venipuncture pain levels</measure>
    <time_frame>1 hour</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Undesirable side effects</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Pain Perception</condition>
  <condition>Phlebotomy</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham-Functional microneedles (no actual microneedles) application, prior to 4% lidocaine gel (LG4) placement.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Microneedle</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Functional microarray (FMA) (microneedles) application, prior to 4% lidocaine gel (LG4) placement.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>4% lidocaine gel application with sham microneedle device</intervention_name>
    <description>Topical 4% lidocaine gel (LG4) applied to subject, after application of sham microneedle device (FMA).</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>4% Lidocaine gel with sham-functional microarray (FMA)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Microneedle-facilitated lidocaine application</intervention_name>
    <description>Application of 4% lidocaine gel (LG4), after application of microneedle (FMA) device</description>
    <arm_group_label>Microneedle</arm_group_label>
    <other_name>4% lidocaine gel with functional microarray</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: age at least 18 years, must provide voluntary consent, weight at least
        50 kg, no allergies to lidocaine, no skin disease, inflammation, or infection at the
        venipuncture sites to be tested

        Exclusion Criteria: cannot have any major dermatologic disease history, known liver
        abnormalities, women who are currently breastfeeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephen H. Thomas, MD MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Oklahoma</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Oklahoma Schusterman Clinic</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74135</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 14, 2010</study_first_submitted>
  <study_first_submitted_qc>June 15, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 16, 2010</study_first_posted>
  <last_update_submitted>March 14, 2017</last_update_submitted>
  <last_update_submitted_qc>March 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>venipuncture</keyword>
  <keyword>phlebotomy</keyword>
  <keyword>pain perception</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

